IDEAYA Biosciences, Inc.
IDYA· Nasdaq
IDYAIDEAYA Biosciences, Inc.
Filed Mar 7, 2023 · 10-K · 66 days after period end · 0000950170-23-006456
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 |
|---|---|---|---|---|
| Revenue | $4.02M | $2.96M | — | — |
| Net Income | -$24.20M | -$18.21M | -$5.14M | -$10.78M |
| EPS Diluted | — | — | — |
IDEAYA Biosciences, Inc. · CIK 1676725 · Engraved from SEC EDGAR
| -$0.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Mar 7, 2023 · 66 d after period end
